MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.730
-0.020 (-1.14%)
At close: Feb 4, 2026, 4:00 PM EST
1.700
-0.030 (-1.73%)
After-hours: Feb 4, 2026, 4:25 PM EST
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $109.44 million as of February 4, 2026. Its market cap has decreased by -41.88% in one year.
Market Cap
109.44M
Enterprise Value
681.85K
1-Year Change
-41.88%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $109.44M, a decrease of -81.77%. That is a compound annual growth rate of -12.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 110.70M | 8.74% |
| Dec 31, 2025 | 101.80M | -50.10% |
| Dec 31, 2024 | 204.00M | -65.81% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
| Oct 10, 2013 | 600.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korro Bio | 125.53M |
| Spero Therapeutics | 123.38M |
| Turn Therapeutics | 121.31M |
| Karyopharm Therapeutics | 119.38M |
| Cardiff Oncology | 117.88M |
| Genelux | 117.80M |
| Verrica Pharmaceuticals | 112.41M |
| Codexis | 112.00M |